Asia-Pacific Infectious Diagnostics Market Outlook to 2021

1. Asia-Pacific Infectious Diagnostics Market Outlook to 2021

2. Report Description Summary Asia-Pacific Infectious Diagnostics Market Outlook to 2021, provides key market data on the Asia-Pacific Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis. Get complete Report @ http://www.bigmarketresearch.com/asia-pacific-infectious-diagnostics-outlook-to-2021-market

3. Report Description Scope - Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Infectious Diagnostics market. - Global corporate-level profiles of key companies operating within the Asia-Pacific Infectious Diagnostics market. - Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc.. Enquire About this report @ http://www.bigmarketresearch.com/report-enquiry/377981

4. Report Description Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.

5. Table of Contents Table Of Contents 1 Table of Contents 2 2 Introduction 7 2.1 What Is This Report About? 7 2.2 Infectious Diagnostics Market Segmentation 7 2.3 Definitions of Markets Covered in the Report 8 3 Infectious Diagnostics Market, Asia-Pacific 10 3.1 Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), 2007-2021 10 3.2 Infectious Diagnostics Market, Asia-Pacific, Category Comparison by Revenue ($m), 2007-2021 12 3.3 Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), 2007-2014 14 3.4 Infectious Diagnostics Market, Asia-Pacific, Revenue ($m), 2014-2021 16 3.5 Infectious Diagnostics Market, Asia-Pacific, Company Share by Revenue ($m), 2014 18 4 Infectious Diagnostics Market, Australia 20 4.1 Infectious Diagnostics Market, Australia, Revenue ($m), 2007-2014 20 4.2 Infectious Diagnostics Market, Australia, Revenue ($m), 2014-2021 22 4.3 Infectious Diagnostics Market, Australia, Distribution Share by Revenue ($m), 2013-2014 4.4 Infectious Diagnostics Market, Australia, Company Share by Revenue ($m), 2014 29

6. Table of Contents 5 Infectious Diagnostics Market, China 31 5.1 Infectious Diagnostics Market, China, Revenue ($m), 2007-2014 31 5.2 Infectious Diagnostics Market, China, Revenue ($m), 2014-2021 33 5.3 Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), 2013-2014 39 5.4 Infectious Diagnostics Market, China, Company Share by Revenue ($m), 2014 40 6 Infectious Diagnostics Market, India 42 6.1 Infectious Diagnostics Market, India, Revenue ($m), 2007-2014 42 6.2 Infectious Diagnostics Market, India, Revenue ($m), 2014-2021 44 6.3 Infectious Diagnostics Market, India, Distribution Share by Revenue ($m), 2013-2014 50 6.4 Infectious Diagnostics Market, India, Company Share by Revenue ($m), 2014 51 7 Infectious Diagnostics Market, Japan 53 7.1 Infectious Diagnostics Market, Japan, Revenue ($m), 2007-2014 53 7.2 Infectious Diagnostics Market, Japan, Revenue ($m), 2014-2021 55 7.3 Infectious Diagnostics Market, Japan, Distribution Share by Revenue ($m), 2013-2014 61 7.4 Infectious Diagnostics Market, Japan, Company Share by Revenue ($m), 2014 62

7. Table of Contents 8 Infectious Diagnostics Market, South Korea 64 8.1 Infectious Diagnostics Market, South Korea, Revenue ($m), 2007-2014 64 8.2 Infectious Diagnostics Market, South Korea, Revenue ($m), 2014-2021 66 8.3 Infectious Diagnostics Market, South Korea, Distribution Share by Revenue ($m), 2013-2014 72 8.4 Infectious Diagnostics Market, South Korea, Company Share by Revenue ($m), 2014 73 9 Overview of Key Companies in Asia-Pacific Infectious Diagnostics Market 75 9.1 Abbott Laboratories 75 9.2 F. Hoffmann-La Roche Ltd. 75 9.3 Siemens Healthcare 75 9.4 Danaher Corporation 76 9.5 Transasia Bio-Medicals Ltd. 76 9.6 Qiagen N.V. 76 9.7 Bio-Rad Laboratories, Inc. 77 9.8 Alere Inc. 77 9.9 Becton, Dickinson and Company 77 9.10 bioMerieux S.A. 78 9.11 Hologic, Inc. 78 9.12 DiaSorin S.p.A 78

8. FOR MORE DETAILS Visit us at : http://www.bigmarketresearch.com/asia-pacific-infectious-diagnostics-outlook-to-2021-market Stay With Us: • TELEPHONE: + 1-800-910-6452 • EMAIL: help@bigmarketresearch.com • 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States